Janssen Scientific Affairs, LLC
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$105.5M
Doctors Paid
27,016
Transactions
92,868
2024 Total
$11.0M
Payment Breakdown by Category
Research$30.6M (29.0%)
Consulting$12.3M (11.6%)
Travel$6.1M (5.7%)
Food & Beverage$4.4M (4.2%)
Royalty/License$220,406 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $40.6M | 15,003 | 38.4% |
| Unspecified | $30.6M | 1,933 | 29.0% |
| Consulting Fee | $12.3M | 5,238 | 11.6% |
| Grant | $11.4M | 378 | 10.8% |
| Travel and Lodging | $6.1M | 10,855 | 5.7% |
| Food and Beverage | $4.4M | 59,438 | 4.2% |
| Royalty or License | $220,406 | 16 | 0.2% |
| Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program | $8,680 | 5 | 0.0% |
| Space rental or facility fees (teaching hospital only) | $1,500 | 1 | 0.0% |
| Education | $295.00 | 1 | 0.0% |
Payments by Type
General
$74.9M
90,935 transactions
Research
$30.6M
1,933 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| DCRI Learning Registry | $7.1M | 0 | 43 |
| Antipsychotic Utilization, Treatment Patterns, Healthcare Resource Use, and Costs among Medicare Beneficiaries with Schizophrenia in the United States (PALM-1035) | $3.2M | 0 | 17 |
| Scrips Health DBA Scripps Genomic Medicine mHealth Screening To Prevent Strokes | $1.0M | 0 | 13 |
| An Open-label, Randomized, Controlled, Multicenter Study Exploring Two Treatment Strategies of Rivaroxaban and a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy in Subjects With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention | $905,525 | 0 | 17 |
| DAH-C-23-USA-016-V01 | $813,462 | 0 | 84 |
| Janssen Diagnostics' Leading Edge Initiative Program | $801,279 | 0 | 6 |
| IRONMAN: International Registry for Men with Advanced Prostate Cancer | $625,000 | 0 | 5 |
| National Pregnancy Registry for Antidepressants (NPRAD) | $609,997 | 0 | 12 |
| ARAMIS (Addressing Real-world Anticoagulant Management Issues in Stroke) Registry at DCRI | $609,020 | 0 | 7 |
| Study of Natural History and Burden of Disease for Patients with X-Linked Retinitis Pigmentosa (XLRP) | $521,762 | 0 | 1 |
| TEC_2864 Real-World Study of Teclistamab Utilization and Outcomes in Relapsed/Refractory Multiple Myeloma - A Multiphase, Multicenter Retrospective Observational Study in U.S. academic centers | $442,490 | 0 | 3 |
| PCSCVMA0011 | $419,171 | 0 | 1 |
| Research Services Agreement between Sharp Memorial Hospital and Janssen Scientific Affairs, LLC | $400,056 | 0 | 2 |
| Research Agreement between Janssen Scientific Affairs, LLC and Duke University Stroke Prevention in Atrial Fibrillation | $352,680 | 0 | 4 |
| Understanding PAD Management Patterns In An Integrated Healthcare System To Identify Opportunities To Improve Clinical Outcomes In Overall ASCVD Risk Reduction and Management With a Focus on PAD | $351,980 | 0 | 3 |
| US Oncology Integrated Solutions Inc Split Dose Darzalex (Daratumumab) study | $313,281 | 0 | 7 |
| Identifying Disparities in Peripheral Artery Disease Experiences & Outcomes | $282,912 | 0 | 5 |
| Impact of paliperidone palmitate on clinical, economic, and psychosocial outcomes in patients with schizophrenia from a health system perspective | $267,154 | 0 | 10 |
| Impact of Treatment of Depression Symptoms on Health Care Utilization and Cost | $266,752 | 0 | 7 |
| An observational retrospective analyses using existing data collected from multiple US IBD centers to evaluate the effectiveness of Ustekinumab for Crohns Disease. | $251,353 | 0 | 6 |
| Kaiser Permanente Northwest Non-Traditional Predictors of Heart Failure Hospitalization and Re-Hospitalization | $218,664 | 0 | 4 |
| ESK-871 Time Equivalent Values For Comparative Effective Analysis of Treatments for Major Depression with Suicidal Ideation Phase 1 | $215,570 | 0 | 8 |
| The Brigham and Womens Hospital Inc Cardiovascular | $215,436 | 0 | 2 |
| Group For Research and Assessment of Psoriasis and Psoriatic Arthritis DUET project | $200,000 | 0 | 1 |
| MYLUNG | $193,300 | 18 | 317 |
| PASCAL Research Program | $190,675 | 7 | 85 |
| Improving Oncology PHM in Prostate Cancer through (PRO) and Cancer.com | $188,512 | 0 | 5 |
| Examining Characteristics, Treatment Patterns, Economic and Clinical Outcomes for Patients with Major Depressive Disorder with Moderate to Severe Anhedonia in Real-World Settings | $187,351 | 0 | 4 |
| Caregivers and Patients Costs of Treatment-Resistant Depression - Indirect Costs and Humanistic Outcomes | $182,830 | 0 | 7 |
| Characterizing Current Treatment and Gaps in the Inflammatory Bowel Disease Population in a Community Setting | $167,500 | 0 | 3 |
Payments by Medical Specialty
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2024 |
|---|---|---|---|---|
| Dr. Neil Love, M.d, M.D | Medical Oncology | Miami, FL | $5.6M | $0 |
| Dr. Allan Gibofsky, Md, MD | Rheumatology | New York, NY | $764,387 | $0 |
| Steven Feldman, Md, MD | Dermatology | Winston Salem, NC | $667,225 | $0 |
| Gerald Dryden, Md, MD | Gastroenterology | Louisville, KY | $553,357 | $0 |
| David Cohen, Md, MD | Dermatology | Macon, GA | $523,174 | $0 |
| Jana Johnson, M.d, M.D | Dermatology | Sioux Falls, SD | $477,694 | $0 |
| Neil Niren, Md, MD | Dermatology | Orlando, FL | $448,165 | $0 |
| Sudhakar Tumuluri, M.d, M.D | Rheumatology | San Francisco, CA | $412,266 | $0 |
| Arthur Kornbluth, Md, MD | Gastroenterology | New York, NY | $391,567 | $0 |
| Aaron Broadwell, Md, MD | Rheumatology | Shreveport, LA | $386,111 | $0 |
| Dr. Scott Gottlieb, M.d, M.D | Dermatology | Exton, PA | $379,693 | $0 |
| Dr. Keith Choate, M.d., Ph.d, M.D., PH.D | Dermatology | New Haven, CT | $352,875 | $0 |
| Charles Sninsky, Md, MD | Gastroenterology | Gainesville, FL | $347,400 | $0 |
| Dr. Jeffrey Crowley, M.d, M.D | MOHS-Micrographic Surgery | Bakersfield, CA | $329,477 | $0 |
| Maya Srivastava, Ms Md Phd, MS MD PHD | Allergy & Immunology | Williamsville, NY | $327,542 | $0 |
| Stephen Hess, Md, MD | Dermatology | Philadelphia, PA | $324,893 | $0 |
| Anthony Turkiewicz, Md, MD | Rheumatology | Mountain Brk, AL | $323,425 | $0 |
| Gordon Lam, Md, MD | Rheumatology | Charlotte, NC | $311,452 | $0 |
| Charles Randall, Md, MD | Gastroenterology | San Antonio, TX | $307,907 | $0 |
| Sergio Schwartzman, M.d, M.D | Rheumatology | New York, NY | $304,583 | $0 |
| Dr. Nitin Gupta, M.d, M.D | Internal Medicine | Atlanta, GA | $301,991 | $0 |
| Douglas Nguyen, Md, MD | Internal Medicine | Mission Viejo, CA | $301,763 | $0 |
| Amar Majjhoo, Md, MD | Rheumatology | Saint Clair Shores, MI | $300,457 | $0 |
| Dr. Glenn Zellman, Md, MD | Procedural Dermatology | Phoenix, AZ | $285,377 | $0 |
| Dr. Marshall Shuler, M.d, M.D | Dermatology | Greenville, SC | $273,527 | $0 |
About Janssen Scientific Affairs, LLC
Janssen Scientific Affairs, LLC has made $105.5M in payments to 27,016 healthcare providers, recorded across 92,868 transactions in the CMS Open Payments database. In 2024, the company paid $11.0M. The top product by payment volume is STELARA ($17.2M).
Payments were distributed across 239 medical specialties. The top specialty by payment amount is Dermatology ($12.2M to 2,533 doctors).
Payment categories include: Food & Beverage ($4.4M), Consulting ($12.3M), Research ($30.6M), Travel & Lodging ($6.1M), Royalties ($220,406).
Janssen Scientific Affairs, LLC is associated with 1 products in the CMS Open Payments database.